Trademark: 79147352
Word
BACHEM PIONEERING PARTNER FOR PEPTIDES
Status
Dead
Status Code
709
Status Date
Friday, December 10, 2021
Serial Number
79147352
Registration Number
4741293
Registration Date
Tuesday, May 26, 2015
Mark Type
5000
Filing Date
Tuesday, April 8, 2014
Published for Opposition
Tuesday, March 10, 2015
Cancellation Date
Friday, December 10, 2021

Trademark Owner History
Bachem Holding AG - Original Registrant

Classifications
5 Pharmaceutical and veterinary products, namely, pharmaceutical preparations for use in the treatment of bleeding, premature labor, pulmonary hypertension, erectile disfunction, coronary syndromes, prostate cancer, endometriosis, central precocious puberty, uterine myoma, osteoporosis, hypercalcernia, Paget's disease, reflex sympathetic dystrophy, nocturnal enureses, central diabetes insipidus, polyuria, polydipsia, hemophilia A, von Willebrand disease, unstable angina, myocardial infarction, hypoglycemia, ovarian follicular cysts, cryptochism, breast cancer, growth hormone deficiency, acromegaly, carcinoid syndrome, thyrotrophic adenomas, diabetes II, VIPosmas, ulcer bleeding, hemorrhagic gastritis, postoperative pancreatic and duodenal fistulae, variceal hemorrhage, neurological diseases, rheumatic diseases, skin diseases, diseases of the intestinal tract, cancer, conjunctivitis, glaucoma, ocular hypertension, Parkinson's disease, transfusion-induced hemosiderosis, candidasis, dermatophytosis, pityriasis, congenital homocystinuria, hyperammonaemia, hepatic encephalopathy, ischemic heart disease, chorioretinal vascular disorders, hypertension, endema, insomnia, bipolar disorder, and schizophrenia; pharmaceutical preparations for use in the diagnosis of gastrinoma; veterinary preparations for use in the induction of ovulation in estrous mares, and reproduction control in dogs and cats; pharmaceutical preparations for use in the diagnosis of Cushing's syndrome, hypothalamic-pituitary-gonadal axis function, growth hormone deficiency, pancreatic exocrine dysfunction, gastrinoma, and adrenocortical insufficiency; dietetic food and substances for medical or veterinary use, namely, taste-modulating food additives in the nature of peptides for medical use, appetite suppressors for medical use; food supplements for humans and animals; fungicides; herbicides
1 Chemicals for use in industry and science, namely, amino acids, peptides, reagents for peptide synthesis, amino acid derivatives, cytokines, enzyme inhibitors, enzyme substrates, growth factors, peptide substrates, all for use as scientific and laboratory research reagents in the field of medicine and molecular biology; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; chemical products used for preserving foodstuffs
The mark consists of the wording "BACHEM" in stylized form above the wording "PIONEERING PARTNER FOR PEPTIDES" in stylized form.
Color is not claimed as a feature of the mark.

Trademark Events
Oct 24, 2022
Total Invalidation Processed By The Ib
Sep 22, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 22, 2022
Invalidation Processed
Aug 10, 2022
Total Invalidation Of Reg Ext Protection Created
Dec 10, 2021
Cancelled Section 71
May 26, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Feb 1, 2019
New Representative At Ib Received
Oct 30, 2015
Final Decision Transaction Processed By Ib
Sep 24, 2015
Final Disposition Notice Sent To Ib
Sep 24, 2015
Final Disposition Processed
Aug 26, 2015
Final Disposition Notice Created, To Be Sent To Ib
May 26, 2015
Registered-Principal Register
Mar 10, 2015
Official Gazette Publication Confirmation E-Mailed
Mar 10, 2015
Published For Opposition
Mar 6, 2015
Notification Processed By Ib
Feb 18, 2015
Notification Of Possible Opposition Sent To Ib
Feb 18, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 18, 2015
Notification Of Notice Of Publication E-Mailed
Jan 30, 2015
Law Office Publication Review Completed
Jan 29, 2015
Assigned To Lie
Jan 9, 2015
Approved For Pub - Principal Register
Jan 9, 2015
Examiner's Amendment Entered
Jan 9, 2015
Notification Of Examiners Amendment E-Mailed
Jan 9, 2015
Examiners Amendment E-Mailed
Jan 9, 2015
Examiners Amendment -Written
Jan 8, 2015
Teas/Email Correspondence Entered
Jan 8, 2015
Correspondence Received In Law Office
Jan 8, 2015
Teas Response To Office Action Received
Aug 8, 2014
Refusal Processed By Ib
Jul 23, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Jul 23, 2014
Refusal Processed By Mpu
Jul 18, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Jul 17, 2014
Non-Final Action Written
Jul 17, 2014
Assigned To Examiner
Jun 3, 2014
Application Filing Receipt Mailed
May 30, 2014
New Application Office Supplied Data Entered In Tram
May 29, 2014
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24